Related Experiment Video
Updated: Jun 16, 2025

08:53
Competitive Transplants to Evaluate Hematopoietic Stem Cell Fitness
Published on: August 31, 2016
15.2K
How I approach intersectionality in hematopoietic stem cell transplantation.
Nada Hamad1,2,3
1Department of Haematology, St. Vincent's Hospital Sydney, Darlinghurst, NSW, Australia.
Blood
|August 19, 2024
Summary
Intersectionality in health care addresses how social inequalities create health disparities. Applying this framework, particularly in hematopoietic stem cell transplantation, can reveal and correct systemic biases for equitable patient outcomes.
Area of Science:
- Health Services Research
- Social Determinants of Health
- Health Equity
Background:
- Intersectionality is a framework analyzing how multiple social inequalities (e.g., race, gender, socioeconomic status) intersect to create health disparities.
- Systemic biases in healthcare, including diagnostic, therapeutic, and prognostic paradigms, can be identified using intersectional analysis.
- Hematopoietic stem cell transplantation (HSCT) is a complex, high-cost procedure where intersectional identities and biases significantly impact patient care and outcomes.
Purpose of the Study:
- To highlight the utility of intersectionality as a framework for understanding and addressing health inequities.
- To examine how intersectional identities and systemic biases manifest in healthcare systems, research, and clinical practice, using HSCT as a case study.
- To advocate for the application of an intersectional approach by transplant clinicians to improve outcomes for marginalized patient populations.
Main Methods:
- Conceptual analysis of intersectionality in healthcare.
- Case study examination of hematopoietic stem cell transplantation (HSCT) to illustrate systemic biases.
- Review of how clinical algorithms and risk assessments may perpetuate inequities due to underrepresentation in data.
Main Results:
- Intersectional identities and systemic biases contribute to unequal health outcomes, particularly evident in complex procedures like HSCT.
- Clinical algorithms derived from non-diverse datasets can embed and perpetuate health inequities.
- Transplant teams are well-positioned to identify and mitigate biases through an intersectional lens.
Conclusions:
- An intersectional approach is crucial for identifying and rectifying systemic biases in healthcare.
- Applying intersectionality in HSCT can lead to more equitable care and improved outcomes for patients facing marginalizing social determinants of health.
- Adopting an intersectional framework is essential for delivering effective, compassionate, and equitable care to all patients.
More Related Videos
Related Concept Videos
Multipotency of Hematopoietic Stem Cells
3.0K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.0K
Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
Bone Marrow Sampling and Transplants
317
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
317
Hematopoiesis
5.2K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.2K
Tissue Transplantation
350
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
350
Stem Cell Therapy for Tissue Regeneration
4.0K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.0K

